Literature DB >> 10747272

International multi-centre evaluation of a dipstick assay for human leptospirosis.

H L Smits1, R A Hartskeerl, W J Terpstra.   

Abstract

A dipstick assay for the detection of Leptospira-specific immunoglobulin M (IgM) antibodies in human sera was evaluated in 27 laboratories in 23 countries. 873 serum samples from 711 patients including 329 laboratory-confirmed leptospirosis case patients, 239 noncase patients and 69 patients with viral infections causing heamorrhagic fever were tested. Relative to the results of the reference leptospirosis test, the sensitivity of the dipstick assay was 84.5% for serum samples collected during the first 10 days of the disease and 92.1% for serum samples collected 10-30 days after the onset of disease. The specificity was 87.5% and 94.4%, respectively. Similar to viral haemorrhagic fevers, leptospirosis may cause bleeding. A small number of serum samples from patients with haemorrhagic viral infections gave a weak (1 +) stain. All other samples were negative. In conclusion, the dipstick assay is sensitive and specific and reacts well with serum samples from patients infected with a range of leptospiral strains. It is also easy to use and does not require special equipment or refrigeration. Therefore the assay is ideal for use in developing countries and rural settings.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10747272     DOI: 10.1046/j.1365-3156.2000.00525.x

Source DB:  PubMed          Journal:  Trop Med Int Health        ISSN: 1360-2276            Impact factor:   2.622


  8 in total

1.  Lateral-flow assay for rapid serodiagnosis of human leptospirosis.

Authors:  H L Smits; C K Eapen; S Sugathan; M Kuriakose; M H Gasem; C Yersin; D Sasaki; B Pujianto; M Vestering; T H Abdoel; G C Gussenhoven
Journal:  Clin Diagn Lab Immunol       Date:  2001-01

2.  Evaluation of four commercially available rapid serologic tests for diagnosis of leptospirosis.

Authors:  Mary D Bajani; David A Ashford; Sandra L Bragg; Christopher W Woods; Tin Aye; Richard A Spiegel; Brian D Plikaytis; Bradley A Perkins; Maureen Phelan; Paul N Levett; Robbin S Weyant
Journal:  J Clin Microbiol       Date:  2003-02       Impact factor: 5.948

3.  Evaluation of four whole-cell Leptospira-based serological tests for diagnosis of urban leptospirosis.

Authors:  Alan J A McBride; Balbino L Santos; Adriano Queiroz; Andréia C Santos; Rudy A Hartskeerl; Mitermayer G Reis; Albert I Ko
Journal:  Clin Vaccine Immunol       Date:  2007-07-25

4.  Evaluation of recombinant Leptospira antigen-based enzyme-linked immunosorbent assays for the serodiagnosis of leptospirosis.

Authors:  B Flannery; D Costa; F P Carvalho; H Guerreiro; J Matsunaga; E D Da Silva; A G Ferreira; L W Riley; M G Reis; D A Haake; A I Ko
Journal:  J Clin Microbiol       Date:  2001-09       Impact factor: 5.948

Review 5.  Leptospirosis in humans.

Authors:  David A Haake; Paul N Levett
Journal:  Curr Top Microbiol Immunol       Date:  2015       Impact factor: 4.291

6.  Leptospirosis in the tropics and in travelers.

Authors:  Jessica N Ricaldi; Joseph M Vinetz
Journal:  Curr Infect Dis Rep       Date:  2006-01       Impact factor: 3.725

7.  Development of transcriptional fusions to assess Leptospira interrogans promoter activity.

Authors:  Gustavo M Cerqueira; Natalie M Souza; Eduardo R Araújo; Aline T Barros; Zenaide M Morais; Sílvio A Vasconcellos; Ana L T O Nascimento
Journal:  PLoS One       Date:  2011-03-18       Impact factor: 3.240

8.  Accuracy of a dual path platform (DPP) assay for the rapid point-of-care diagnosis of human leptospirosis.

Authors:  Scott A Nabity; Guilherme S Ribeiro; Carolina Lessa Aquino; Daniele Takahashi; Alcinéia Oliveira Damião; André H O Gonçalves; Demócrito B Miranda-Filho; Rena Greenwald; Javan Esfandiari; Konstantin P Lyashchenko; Mitermayer G Reis; Marco A Medeiros; Albert I Ko
Journal:  PLoS Negl Trop Dis       Date:  2012-11-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.